Deborah H. Slee - Concepedia

Author

Deborah H. Slee

Neurocrine Biosciences (United States)

Also Known As

D. H. SLEE, D. Slee, Deborah H Slee, Deborah H. Slee, Deborah Slee, Slee, D.H.

Publications

878

Citations

H-Index

Concepts

All Affiliations

Neurocrine Biosciences (United States)Almirall (Spain)University of California, Santa Barbara

About

Deborah H. Slee is an author at Neurocrine Biosciences (United States) specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	456
2	Natural Sciences	8	8	313
3	Engineering	4	4	157
4	Health Sciences	1	1	36
5	Social Sciences	1	1	30

Deborah H. Slee

Publications

824

Citations

H-Index

Page 1

	Year	Citations
Topical delivery of siRNA into skin using SPACE-peptide carriers Ming Chen, Michael Zakrewsky, Vivek Gupta, Journal of Controlled Release NanomedicineEngineeringTopical DrugTopical DeliveryBiomedical Engineering	2014	113
Selectivity in the Inhibition of HIV and FIV Protease: Inhibitory and Mechanistic Studies of Pyrrolidine-Containing .alpha.-Keto Amide and Hydroxyethylamine Core Structures Deborah H. Slee, Karen Laslo, John H. Elder, Journal of the American Chemical Society Altmetric Attention ScorePharmacotherapyAntiviral DrugChemical BiologyPharmaceutical Chemistry	1995	100
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension Anna Galkin, Ravikumar Sitapara, Bryan Clemons, European Respiratory Journal	2022	64
Development of Potent Non-Carbohydrate Imidazole-Based Small Molecule Selectin Inhibitors with Antiinflammatory Activity Deborah H. Slee, Suzanne J. Romano, Jinghua Yu, Journal of Medicinal Chemistry Drug TargetBioorganic ChemistryPharmacotherapyChemical BiologyPharmaceutical Chemistry	2001	63
Topical delivery of Cyclosporine A into the skin using SPACE-peptide Ming Chen, Sunny Kumar, Aaron C. Anselmo, Journal of Controlled Release MedicineCutaneous BiologyTopical DrugTopical DeliverySkin Pharmacology	2014	49
2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub>Receptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents Deborah H. Slee, Yongsheng Chen, Xiaohu Zhang, Journal of Medicinal Chemistry	2008	43
Identification of Novel, Water-Soluble, 2-Amino-<i>N</i>-pyrimidin-4-yl Acetamides as A<sub>2A</sub>Receptor Antagonists with In Vivo Efficacy Deborah H. Slee, Xiaohu Zhang, M. N. Moorjani, Journal of Medicinal Chemistry	2008	41
Selection, synthesis, and structure–activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists Marion Lanier, Miklós Fehér, Neil J. Ashweek, Bioorganic & Medicinal Chemistry Structure–activity RelationshipBiochemistryMedicineNatural SciencesNon-peptide Ligand	2007	41
Inhibition of Fructose-1,6-bisphosphatase by a New Class of Allosteric Effectors Jun-Young Choe, Scott W. Nelson, Kristen L. Arienti, Journal of Biological Chemistry	2003	39
Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A<sub>2A</sub>Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease Xiaohu Zhang, John E. Tellew, Zhiyong Luo, Journal of Medicinal Chemistry PharmacotherapyExperimental PharmacologyPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry	2008	38

Page 1